Stock listing
gettex:GX1 Marker Therapeutics, Inc. Aktie
German listing (gettex) of Marker Therapeutics, Inc. · home listing NASDAQ:MRKR
Follow Marker Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MRKR
$0.98 USD -0.03 (-3.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MRKR
- Day range
- $0.966 – $1.04 USDOct 30, 2026
- Volume
- 67,558 sharesOct 30, 2026
- Market cap
- $16.34M USDAt the close on Oct 30, 2026 · price × 16.67M shares outstanding
- 52-week range
- $0.84 – $2.46 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $121,361 USDMedian day 71,713 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MRKR · Home | $0.98 USD | -0.03 (-3.0%) | 67,558 | $1.03 | $1.04 | $0.966 | $1.01 | Close on Oct 30, 2026 |
| Frankfurt:GX1 | €0.755 EUR | +0.095 (+14.4%) | — | €0.755 | €0.755 | €0.755 | €0.660 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MRKR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.98 | -0.03 | -3.0% | $1.03 | $1.04 | $0.966 | 67,558 | |
| $1.01 | +0.01 | +1.0% | $1.03 | $1.07 | $0.98 | 72,225 | |
| $1.00 | +0.049 | +5.1% | $0.955 | $1.07 | $0.901 | 86,904 | |
| $0.951 | +0.045 | +5.0% | $0.92 | $0.97 | $0.89 | 103,887 | |
| $0.906 | -0.054 | -5.6% | $0.949 | $1.04 | $0.88 | 217,593 | |
| $0.96 | -0.11 | -10.3% | $1.07 | $1.12 | $0.96 | 114,400 | |
| $1.07 | -0.06 | -5.3% | $1.17 | $1.17 | $1.07 | 91,500 | |
| $1.13 | -0.03 | -2.6% | $1.16 | $1.27 | $1.13 | 149,900 | |
| $1.16 | -0.04 | -3.3% | $1.19 | $1.24 | $1.11 | 209,400 | |
| $1.20 | +0.16 | +15.4% | $1.09 | $1.20 | $1.05 | 578,800 | |
| $1.04 | +0.12 | +13.0% | $1.02 | $1.20 | $1.00 | 1,146,100 | |
| $0.92 | +0.03 | +3.4% | $0.96 | $0.96 | $0.88 | 120,200 | |
| $0.89 | -0.03 | -3.3% | $0.92 | $0.95 | $0.89 | 65,800 | |
| $0.92 | -0.09 | -8.9% | $1.03 | $1.03 | $0.91 | 175,200 | |
| $1.01 | +0.04 | +4.1% | $0.98 | $1.03 | $0.98 | 107,800 | |
| $0.97 | +0.02 | +2.1% | $0.93 | $1.00 | $0.93 | 91,200 | |
| $0.95 | -0.09 | -8.7% | $1.04 | $1.05 | $0.95 | 96,900 | |
| $1.04 | +0.03 | +3.0% | $1.03 | $1.06 | $1.03 | 37,500 | |
| $1.01 | -0.05 | -4.7% | $1.07 | $1.07 | $1.00 | 77,100 | |
| $1.06 | +0.01 | +1.0% | $1.08 | $1.09 | $1.05 | 73,500 | |
| $1.05 | 0.00 | 0.0% | $1.06 | $1.08 | $1.02 | 100,300 | |
| $1.05 | -0.02 | -1.9% | $1.08 | $1.09 | $0.98 | 127,500 | |
| $1.07 | -0.03 | -2.7% | $1.12 | $1.14 | $1.07 | 38,400 | |
| $1.10 | -0.03 | -2.7% | $1.14 | $1.16 | $1.08 | 90,900 | |
| $1.13 | -0.02 | -1.7% | $1.12 | $1.15 | $1.07 | 164,300 | |
| $1.15 | -0.04 | -3.4% | $1.22 | $1.22 | $1.15 | 29,600 | |
| $1.19 | -0.05 | -4.0% | $1.26 | $1.31 | $1.15 | 141,600 | |
| $1.24 | +0.02 | +1.6% | $1.24 | $1.27 | $1.23 | 64,900 | |
| $1.22 | +0.02 | +1.7% | $1.18 | $1.24 | $1.18 | 38,700 | |
| $1.20 | +0.02 | +1.7% | $1.18 | $1.22 | $1.18 | 24,200 | |
| $1.18 | 0.00 | 0.0% | $1.19 | $1.23 | $1.17 | 47,300 | |
| $1.18 | +0.04 | +3.5% | $1.13 | $1.23 | $1.13 | 60,600 | |
| $1.14 | -0.03 | -2.6% | $1.17 | $1.18 | $1.13 | 35,900 | |
| $1.17 | 0.00 | 0.0% | $1.17 | $1.23 | $1.15 | 12,000 | |
| $1.17 | +0.02 | +1.7% | $1.16 | $1.23 | $1.16 | 17,400 | |
| $1.15 | -0.05 | -4.2% | $1.20 | $1.25 | $1.10 | 59,400 | |
| $1.20 | -0.01 | -0.8% | $1.21 | $1.23 | $1.18 | 55,500 | |
| $1.21 | -0.07 | -5.5% | $1.29 | $1.29 | $1.21 | 71,200 | |
| $1.28 | +0.10 | +8.5% | $1.19 | $1.39 | $1.19 | 200,300 | |
| $1.18 | -0.06 | -4.8% | $1.25 | $1.31 | $1.18 | 35,300 | |
| $1.24 | -0.01 | -0.8% | $1.24 | $1.31 | $1.22 | 43,400 | |
| $1.25 | -0.05 | -3.8% | $1.25 | $1.33 | $1.24 | 167,600 | |
| $1.30 | -0.03 | -2.3% | $1.31 | $1.34 | $1.26 | 21,000 | |
| $1.33 | -0.04 | -2.9% | $1.37 | $1.41 | $1.31 | 59,500 | |
| $1.37 | -0.09 | -6.2% | $1.50 | $1.50 | $1.35 | 84,800 | |
| $1.46 | +0.01 | +0.7% | $1.45 | $1.50 | $1.40 | 24,500 | |
| $1.45 | -0.07 | -4.6% | $1.52 | $1.59 | $1.45 | 33,800 | |
| $1.52 | +0.02 | +1.3% | $1.50 | $1.60 | $1.48 | 146,700 | |
| $1.50 | +0.11 | +7.9% | $1.44 | $1.53 | $1.41 | 238,000 | |
| $1.39 | +0.17 | +13.9% | $1.25 | $1.44 | $1.25 | 99,400 | |
| $1.22 | -0.07 | -5.4% | $1.28 | $1.32 | $1.19 | 80,600 | |
| $1.29 | +0.14 | +12.2% | $1.19 | $1.36 | $1.16 | 232,200 | |
| $1.15 | -0.01 | -0.9% | $1.16 | $1.18 | $1.15 | 46,100 | |
| $1.16 | +0.02 | +1.8% | $1.18 | $1.20 | $1.14 | 42,900 | |
| $1.14 | +0.03 | +2.7% | $1.14 | $1.16 | $1.12 | 45,600 | |
| $1.11 | -0.05 | -4.3% | $1.15 | $1.16 | $1.11 | 30,000 | |
| $1.16 | +0.04 | +3.6% | $1.10 | $1.20 | $1.09 | 73,100 | |
| $1.12 | -0.03 | -2.6% | $1.13 | $1.15 | $1.09 | 55,600 | |
| $1.15 | +0.03 | +2.7% | $1.10 | $1.15 | $1.10 | 48,600 | |
| $1.12 | 0.00 | 0.0% | $1.14 | $1.14 | $1.11 | 40,100 | |
| $1.12 | -0.02 | -1.8% | $1.15 | $1.25 | $1.12 | 30,400 | |
| $1.14 | -0.09 | -7.3% | $1.23 | $1.27 | $1.10 | 103,100 | |
| $1.23 | +0.01 | +0.8% | $1.24 | $1.29 | $1.23 | 34,000 | |
| $1.22 | +0.09 | +8.0% | $1.16 | $1.31 | $1.16 | 65,400 | |
| $1.13 | +0.01 | +0.9% | $1.15 | $1.20 | $1.11 | 37,400 | |
| $1.12 | +0.01 | +0.9% | $1.11 | $1.14 | $1.05 | 72,900 |
- Ticker
- gettex:GX1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Calls
Replays
Marker Therapeutics (NASDAQ:MRKR) Q2 2022 Earnings Call
Wed, Feb 16, 2022 · 5:00 PM ET
Watch Transcript
Latest news
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Oct 19, 2026
Closed $1.20 (+15.4%) on Oct 19, 2026
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
Mar 18, 2026
Closed $1.34 (-1.5%) on Mar 18, 2026
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 18, 2026
Closed $1.50 (+3.4%) on Feb 18, 2026
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
Jan 26, 2026
Closed $1.87 (-11.0%) on Jan 26, 2026
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
Jan 5, 2026
Closed $1.79 (+16.2%) on Jan 5, 2026
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Nov 14, 2025
Closed $0.92 (+3.4%) on Nov 14, 2025
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Nov 5, 2025
Closed $0.92 (+2.2%) on Nov 5, 2025
Decks
Investor Presentation (November 2025)
Investor deck · 20 slides · November 2025
Investor Presentation (August 2025)
Investor deck · 28 slides · Aug 26, 2025
Investor Presentation (August 2025)
Investor deck · 20 slides · Aug 26, 2025
Investor Presentation (January 2024)
Investor deck · 21 slides · Jan 8, 2024
Marker Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 105 in all · newest Oct 19, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Feb 16, 2022
- Decks
- 12 decks · latest November 2025
Where Marker Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MRKR · Home listing | NASDAQ | United States | USD |
| gettex:GX1 · This page | gettex | Germany | EUR |
| BOATS:MRKR | BOATS | United States | USD |
| Frankfurt:GX1 | Frankfurt | Germany | EUR |
| Munich:GX1 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Marker Therapeutics, Inc.